Perceptive Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-9,132
| Closed | -$739K | – | 135 |
|
|
2018
Q1 | $739K | Buy |
+9,132
| New | +$739K | 0.02% | 111 |
|
|
2016
Q2 | – | Sell |
-17,507
| Closed | -$514K | – | 171 |
|
|
2016
Q1 | $514K | Buy |
+17,507
| New | +$514K | 0.05% | 115 |
|
|
2015
Q3 | – | Sell |
-4,956
| Closed | -$223K | – | 149 |
|
|
2015
Q2 | $223K | Buy |
+4,956
| New | +$223K | 0.01% | 146 |
|
|
2014
Q4 | – | Sell |
-3,040
| Closed | -$120K | – | 144 |
|
|
2014
Q3 | $120K | Buy |
+3,040
| New | +$120K | 0.01% | 93 |
|